Plasma phospholipids identify antecedent memory impairment in older adults.

Nat Med 2014 Apr 9;20(4):415-8. Epub 2014 Mar 9.

1] Department of Neurology, Georgetown University Medical Center, Washington, DC, USA. [2] Department of Neuroscience, Georgetown University Medical Center, Washington, DC, USA.

Alzheimer's disease causes a progressive dementia that currently affects over 35 million individuals worldwide and is expected to affect 115 million by 2050 (ref. 1). There are no cures or disease-modifying therapies, and this may be due to our inability to detect the disease before it has progressed to produce evident memory loss and functional decline. Biomarkers of preclinical disease will be critical to the development of disease-modifying or even preventative therapies. Unfortunately, current biomarkers for early disease, including cerebrospinal fluid tau and amyloid-β levels, structural and functional magnetic resonance imaging and the recent use of brain amyloid imaging or inflammaging, are limited because they are either invasive, time-consuming or expensive. Blood-based biomarkers may be a more attractive option, but none can currently detect preclinical Alzheimer's disease with the required sensitivity and specificity. Herein, we describe our lipidomic approach to detecting preclinical Alzheimer's disease in a group of cognitively normal older adults. We discovered and validated a set of ten lipids from peripheral blood that predicted phenoconversion to either amnestic mild cognitive impairment or Alzheimer's disease within a 2-3 year timeframe with over 90% accuracy. This biomarker panel, reflecting cell membrane integrity, may be sensitive to early neurodegeneration of preclinical Alzheimer's disease.

Download full-text PDF

Source
http://www.cogsci.ucsd.edu/~mboyle/COGS163/pdf-files/W9-Plas
Web Search
http://www.utstat.utoronto.ca/reid/sta2201s/2014/nm.3466-S1.
Web Search
http://www.nature.com/doifinder/10.1038/nm.3466
Publisher Site
http://dx.doi.org/10.1038/nm.3466DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360460PMC
April 2014
43 Reads

Publication Analysis

Top Keywords

alzheimer's disease
20
preclinical alzheimer's
12
older adults
8
disease
8
alzheimer's
5
limited invasive
4
blood-based biomarkers
4
expensive blood-based
4
biomarkers attractive
4
invasive time-consuming
4
time-consuming expensive
4
attractive option
4
sensitivity specificity
4
specificity describe
4
describe lipidomic
4
required sensitivity
4
disease required
4
option currently
4
currently detect
4
detect preclinical
4

References

(Supplied by CrossRef)

RA Sperling et al.
Alzheimer's & Dementia: the Journal of the Alzheimer's Association 2011

F Hulstaert et al.
Neurology 1999

SA Small et al.
Ann. Neurol. 1999

WE Klunk et al.
Ann. Neurol. 2004

C Franceschi et al.
Ann. NY Acad. Sci. 2000

M Thambisetty et al.
Biomark. Med. 2010

R Tibshirani et al.
J. R. Stat. Soc. Ser. B Stat. Methodol. 1996

G van Meer et al.
J. Cell Sci. 2011

LL Jones et al.
Prog. Lipid Res. 2010

Similar Publications